A rare clinical case of diagnosis and treatment of metastases of Merkel carcinoma in the right inguinal lymph nodes without an identified primary focus

Cover Page

Cite item

Full Text

Abstract

Introduction. Merkel’s carcinoma is a neuroendocrine malignant epithelial skin tumor, rapidly progressive, prone to local recurrence and metastasis to regional lymph nodes and internal organs. The etiology and pathogenesis of Merkel’s carcinoma are still an insufficiently studied issue. Because of its rare occurrence, only single observations of Merkel’s carcinoma metastasis without an identified primary focus, most often with regional lymph node involvement, have been described in the world literature.

Clinical case. This article presents a clinical case of metastatic lesion of inguinal lymph nodes with microinvasion into femoral artery in Merkel’s carcinoma without identified primary focus. After a comprehensive examination and onco-consilium the patient underwent surgical treatment in the scope of cytoreductive excision of the inguinal lymph node conglomerate on the right side and artery prosthesis with an autovenous graft. According to the routine postoperative pathomorphologic and immunohistochemical studies, the diagnosis of Merkel’s carcinoma metastasis was finally confirmed.

Conclusion. Identification and description of such clinical cases are practically significant and can serve for formation of certain algorithms for treatment of Merkel’s carcinoma both with local manifestations and in progressive forms. Patients with Merkel’s carcinoma should be discussed in oncological consiliums, as treatment may include surgical stage, including biopsy of sentinel lymph nodes, adjuvant radiotherapy, chemotherapy and immunotherapy in case of tumor dissemination.

About the authors

K. S. Titov

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department; Peoples’ Friendship University of Russia

Author for correspondence.
ORCID iD: 0000-0003-4460-9136

5 2nd Botkinskij Proezd, Moscow 125284

6 Miklukho-Maklaya St., Moscow 117198

Russian Federation

I. N. Lebedinsky

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

ORCID iD: 0000-0001-7735-1106

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

M. M. Magomedova

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

Email: malikatmagomedova98@gmail.com
ORCID iD: 0000-0003-0706-6128

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

S. R. Dzhamilov

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

ORCID iD: 0000-0002-1445-7277

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

D. N. Grekov

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department; Russian Medical Academy of Continuing Professional Education

ORCID iD: 0000-0001-8391-1210

5 2nd Botkinskij Proezd, Moscow 125284

Bld. 1, 2/1 Barrikadnaya St., Moscow 125993

Russian Federation

M. V. Sorokina

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

ORCID iD: 0000-0002-4436-8101

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

Yu. V. Karabach

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

References

  1. Xue Y., Thakuria M. Merсel cell carcinoma review. Hematol Oncol Clin North Am 2019;33(1):39–52. doi: 10.1016/j.hoc.2018.08.002
  2. Liapakis I.E., Korkolis D.P., Koutsoumbi A. et al. Merkel cell carcinoma: clinicopathological aspects of an unusual neoplasm. J BUON 2007;12(2):173–9.
  3. Yaramada P., Lim B.S., Flannery C.M. et al. Merkel cell carcinoma of unknown primary with lymph node and mesenteric metastasis involving the pancreas and duodenum. J Gastrointest Oncol 2016;7(Suppl. 1):S66–70. doi: 10.3978/j.issn.2078-6891.2015.043
  4. Gauci M.L., Aristei C., Becker J.C. et al. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022. Eur J Cancer 2022;171:203–31. doi: 10.1016/j.ejca.2022.03.043
  5. Shalhout S.Z., Emerick K.S., Kaufman H.L., Miller D.M. Immunotherapy for non-melanoma skin cancer. Curr Oncol Rep 2021;23(11):125. doi: 10.1007/s11912-021-01120-z
  6. Paulson K.G., Park S.Y., Vandeven N.A. et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol 2018;78(3):457–63.e2. doi: 10.1016/j.jaad.2017.10.028
  7. Поляков А.П., Титов К.С. Злокачественные опухоли кожи: учеб. пособие. М., 2020. Polyakov A.P., Titov K.S. Malignant skin tumors: studies. Moscow, 2020. (In Russ.).
  8. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319(5866):1096–100. doi: 10.1126/science.1152586
  9. Merkel cell carcinoma. NCCN Clinical practice guidelines in oncology. 2019. 10.Moshiri A.S., Doumani R., Yelistratova L. et al. Polyomavirus-negative merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection. J Investig Dermatol 2017;137(4):819–27. doi: 10.1016/j.jid.2016.10.028
  10. Harms K.L., Healy M.A., Nghiem P. et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol 2016;23(11):3564–71. doi: 10.1245/s10434-016-5266-4

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Titov K.S., Lebedinsky I.N., Magomedova M.M., Dzhamilov S.R., Grekov D.N., Sorokina M.V., Karabach Y.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.